Patient-Friendly Explanation

MASH is the serious, inflamed form of fatty liver disease that happens when fat build-up in the liver causes damage and inflammation. If left untreated, it can progress to scarring of the liver (cirrhosis) and liver failure. Weight loss is one of the most effective ways to reverse it.

Clinical Definition

Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, is defined as the presence of steatosis with hepatocyte injury (ballooning) and lobular inflammation, with or without fibrosis, in the setting of metabolic dysfunction. It is a key driver of progression to cirrhosis and hepatocellular carcinoma, affecting an estimated 5% of the global population. Weight loss of 7 to 10% achieved through lifestyle intervention or pharmacotherapy has been shown to resolve steatohepatitis and improve fibrosis in a dose-dependent manner.

Why It Matters

Because significant weight loss can reverse MASH, identifying it early is an important reason for patients to start a structured programme like the one at NuLifeCare Singapore.